Showing 33,801 - 33,820 results of 226,652 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( i largest decrease ))', query time: 2.03s Refine Results
  1. 33801

    KDM2A interacts with Rb and E2F1 in a cell cycle specific manner. by Wasia Rizwani (369727)

    Published 2014
    “…Interaction of KDM2A with E2F1 decreases at 8 hr of serum stimulation. …”
  2. 33802

    Coalescence of an Oil Droplet with a Permeating One over a Membrane Surface: Conditions of Permeation, Recoil, and Pinning by Amgad Salama (5620166)

    Published 2021
    “…When a droplet lands over a nonwetting surface it forms a convex interface that makes a contact angle larger than 90°. …”
  3. 33803

    Biological effect of lncRGMB-AS1 downregulation on cell proliferation in A549 and SPC-A-1 cells. by Ping Li (31981)

    Published 2016
    “…(C, D) CCK-8 assays showed that the OD<sub>450</sub> values for the siRNA group on days 2, 3 and 4 were significantly decreased in both A549 and SPC-A-1 cells (<i>P</i> < 0.05) in comparison with the control groups (<i>P</i> > 0.05). …”
  4. 33804

    Probing the Sensitivity of the Orbitrap Lumos Mass Spectrometer Using a Standard Reference Protein in a Complex Background by Michaella J. Levy (1564081)

    Published 2018
    “…The use of mass spectrometry as a tool to detect proteins of biological interest has become a cornerstone of proteomics. …”
  5. 33805

    Supplementary Material for: A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve by Thomson B.K.A. (11712230)

    Published 2021
    “…We explored the evidence for alternative anticoagulation strategies in patients with ESRD with a contraindication for VKA therapy. <b><i>Methods:</i></b> A scoping review was completed, searching MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Conference abstracts from inception to March 30, 2021. …”
  6. 33806

    Data Sheet 1_A rare PBX1 variant identified in adulthood: a case report.docx by Ah-Rim Han (2481865)

    Published 2025
    “…As part of the initial workup for decreased renal function and proteinuria, a kidney biopsy was performed, revealing focal segmental glomerulosclerosis (FSGS) and acute tubular necrosis without an identifiable cause. …”
  7. 33807

    Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice by Cristiana C. Garcia (173379)

    Published 2010
    “…<div><p>Influenza A virus causes annual epidemics which affect millions of people worldwide. …”
  8. 33808

    CavA and Vfr are regulators of global intracellular c-di-GMP levels in <i>A. baumannii</i>. by Lyuboslava G. Harkova (19557062)

    Published 2024
    “…Deletion of <i>cavA</i> reduced c-di-GMP levels by 66% (<b>A</b>) while disruption of <i>vfr</i> decreased them by 49% (<b>B</b>). …”
  9. 33809

    A Sensory-Driven Trade-Off between Coordinated Motion in Social Prey and a Predator’s Visual Confusion by Bertrand H. Lemasson (636640)

    Published 2016
    “…Interestingly, while a complete loss of coordination in the prey (e.g., a flash expansion) caused the greatest delay in capture, such behavior had little effect on capture accuracy. …”
  10. 33810

    Beyond Estrogenicity: A Comparative Assessment of Bisphenol A and Its Alternatives in In Vitro Assays Questions Safety of Replacements by Vanessa Srebny (12565963)

    Published 2025
    “…Simulated phase I metabolism reduced the cytotoxicity of all alternatives except for methyl bis(4-hydroxyphenyl)acetate (Bz) and 4-[[4-(allyloxy)phenyl]sulfonyl]phenol (BPS-MAE), while estrogenic activity remained unchanged or decreased. This study demonstrates the utility of bioassays for rapid hazard assessment and comparative evaluation, suggesting that many BPA alternatives are regrettable substitutes, although 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD) is a potentially more benign alternative.…”
  11. 33811

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  12. 33812

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  13. 33813

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  14. 33814

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  15. 33815

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  16. 33816

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  17. 33817

    Table1_A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer.DOCX by Sheng Liu (279488)

    Published 2024
    “…<p>Hepatitis A virus cellular receptor (HAVCR1) is a type-1 integral membrane glycoprotein that plays a key role in immunity and renal regeneration and is abnormally expressed in various tumor types. …”
  18. 33818

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  19. 33819

    Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population by Maral DerSarkissian (504144)

    Published 2018
    “…</p> <p><b>Methods:</b> A retrospective observational longitudinal study of subjects with obesity was conducted using the General Electric Centricity electronic medical record database. …”
  20. 33820

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”